microdosing oral semaglutide Benefits of GLP-1 GLP-1 (glucagon-like peptide-1) receptor agonists, such as tirzepatide (Zepbound) or (Ozempic, Wegovy), are typically prescribed for diabetes and obesity management at standard therapeutic doses. Microdosing Americans are microdosing obesity drugs,

severe or persistent upper abdominal pain should prompt urgent medical assessment [10] [11] Dehydration and acute kidney injury (AKI): gastrointestinal fluid losses can lead to dehydration, which may precipitate AKI, particularly in those with pre-existing renal impairment or those taking nephrotoxic medicines Delayed gastric emptying: this may affect the absorption of orally administered medicines, including contraceptive pills and thyroid replacement therapy [11] Injection site reactions: redness, bruising, or discomfort at the subcutaneous injection site Heart rate changes: increases in resting heart rate have been noted with GLP-1 class agents [14] [15] Hypoglycaemia: particularly if used alongside insulin or sulphonylureas Potential pancreatitis risk: a class concern with GLP-1 receptor agonists

You can join the waitlist for Retatrutide and complete the consultation form on our website to find out if this treatment suits your needs

A GLP-1 medicine requires a prescription

GLP-1 receptor agonists can trigger nausea by acting on CNS pathways, which is why some providers believe B6 may help mitigate these effects